Biotecan participates in the nucleic acid test of the Transit Inspection Warehouse, escorting cold chain food safety28 June 2021 [BIOTECAN]
In the early morning of the 20th, four people from the Kanhaixuan community in Dongjiang Port District in Tianjin were diagnosed with confirmed cases of local novel coronary pneumonia. At 2 a.m. of the 20th, the Kanhaixuan community has been upgraded from a medium-risk area to a high-risk area. At present, there are sporadic cases in many places in the country, so it is still urged to control the cases from both local and abroad.
Recently, Shanghai issued the "Implementing Transit Inspection of High-risk Imported Cold Chain Foods Act", requiring high-risk imported cold chain foods to enter the transit inspection warehouse for both nucleic acid test and packaging disinfection. This Act have been formally implemented from November the 16th. Biotecan recently undertook the task of nucleic acid testing of cold chain food in Transit Inspection Warehouses to ensure cold chain food safety.
As a key epidemic prevention enterprise in Shanghai and a nucleic acid testing agency designated by the Shanghai Municipal Health Commission, Biotecan has been actively fulfilling the mission and responsibilities of the company to help precise prevention and control of the epidemic.
Recently, we continuously sent our team to the Transit Inspection Warehouse to sample the imported cold chain food, and complete the nucleic acid testing task, contributing to cutting off the possible spread of the virus and building a health and safety barrier.
Since the outbreak of the epidemic, the company has quickly built a technical forces and established a complete virus diagnosis solution. With excellent results, we passed the 2020 National Health Commission's Novel Coronavirus Nucleic Acid Testing Laboratory Quality Assessment and Shanghai Clinical Laboratory Center's COVID-19 Nucleic Acid Testing Capability Verification, designated by the Shanghai Municipal Health Commission as a novel coronavirus nucleic acid testing agency. At the same time, our team has actively participated in the first-line anti-epidemic tasks, undertaking the COVID diagnosis and screening tasks in more than 20 cities in China, and we were honored as the Shanghai key epidemic prevention enterprise.
In the normalization stage of epidemic prevention, Biotecan will give full play to our technological advantages, bravely assume social responsibilities, actively assist in epidemic prevention and contribute to the full victory in epidemic fight.